LINC02763

Across TCGA pan-cancer cohorts, LINC02763 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02763 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02763 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02763 expression acts as an unfavorable survival marker, although some lineages such as MESO and CHOL show a favorable association.

COAD, BRCA, and MESO are the cancer types where LINC02763 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Quartile	All	0.487	0.631	.004	67	view →
BRCA	DFS	Quartile	III,IV	0.675	0.831	.004	54	view →
MESO	OS	Tertile	All	0.500	0.256	<.001	43	view →
STAD	OS	Quartile	III,IV	0.507	0.735	.007	42	view →
CHOL	DFS	Median	All	0.861	0.126	.001	30	view →
KIRC	DFS	Quartile	All	0.527	0.695	.014	30	view →
LGG	OS	Quartile	All	0.645	0.388	.002	28	view →
ACC	DFS	Quartile	II,III,IV	0.288	0.716	.008	28	view →
SARC	DFS	Tertile	All	0.719	0.549	.001	16	view →
UCS	OS	Quartile	III,IV	0.362	0.657	.008	12	view →
THYM	OS	Median	All	0.956	0.587	.007	10	view →
BLCA	OS	Median	III,IV	0.506	0.306	.011	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC02763–COAD (OS)

Open the COAD breakdown →